z-logo
open-access-imgOpen Access
Heterogeneity of Coenzyme Q10Deficiency
Author(s) -
Valentina Emmanuele,
Luís C. López,
Andrés Berardo,
Ali Naini,
Saba Tadesse,
Bing Wen,
Erin D’Agostino,
Martha Solomon,
Salvatore DiMauro,
Catarina M. Quinzii,
Michio Hirano
Publication year - 2012
Publication title -
archives of neurology
Language(s) - English
Resource type - Journals
eISSN - 1538-3687
pISSN - 0003-9942
DOI - 10.1001/archneurol.2012.206
Subject(s) - ataxia , coenzyme q10 , medicine , cerebellar ataxia , mitochondrial myopathy , pediatrics , coenzyme q – cytochrome c reductase , myopathy , gastroenterology , endocrinology , biology , genetics , mitochondrion , cytochrome c , psychiatry , mitochondrial dna , gene
Coenzyme Q(10) (CoQ(10)) deficiency has been associated with 5 major clinical phenotypes: encephalomyopathy, severe infantile multisystemic disease, nephropathy, cerebellar ataxia, and isolated myopathy. Primary CoQ(10) deficiency is due to defects in CoQ(10) biosynthesis, while secondary forms are due to other causes. A review of 149 cases, including our cohort of 76 patients, confirms that CoQ(10) deficiency is a clinically and genetically heterogeneous syndrome that mainly begins in childhood and predominantly manifests as cerebellar ataxia. Coenzyme Q(10) measurement in muscle is the gold standard for diagnosis. Identification of CoQ(10) deficiency is important because the condition frequently responds to treatment. Causative mutations have been identified in a small proportion of patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom